Atypical presentation of Behçet's disease with central nervous system involvement successfully treated with infliximab

Rheumatol Int. 2012 May;32(5):1431-5. doi: 10.1007/s00296-011-1915-x. Epub 2011 Mar 29.

Abstract

Central nervous system involvement is a rare and serious complication of Behçet's disease (BD). Herein, we describe a patient with an atypical central lesion, who experienced progressive hypesthesia of the right arm and sensory loss of the trigeminal nerve together with intense headache. A repeated biopsy was necessary to conclusively establish the diagnosis of BD. Therapy with infusions of infliximab led to a remarkable full remission. TNFα-blocking therapy was successfully replaced by azathioprine. The present well-illustrated case demonstrates the difficulty of establishing the diagnosis of BD with central nervous system involvement, the dramatic benefit of short given TNF-α-blocking agent, and the long-term remission with azathioprin.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage*
  • Azathioprine / administration & dosage
  • Behcet Syndrome / complications
  • Behcet Syndrome / diagnosis
  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / immunology
  • Biopsy
  • Central Nervous System Diseases / drug therapy*
  • Central Nervous System Diseases / etiology
  • Central Nervous System Diseases / immunology
  • Central Nervous System Diseases / physiopathology
  • Drug Administration Schedule
  • Drug Substitution
  • Female
  • Headache / drug therapy
  • Headache / etiology
  • Headache / immunology
  • Humans
  • Hypesthesia / drug therapy
  • Hypesthesia / immunology
  • Hypesthesia / physiopathology
  • Immunohistochemistry
  • Immunosuppressive Agents / administration & dosage*
  • Infliximab
  • Magnetic Resonance Imaging
  • Remission Induction
  • Treatment Outcome
  • Trigeminal Nerve / drug effects
  • Trigeminal Nerve / physiopathology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Upper Extremity / innervation*

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Azathioprine